Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo.
about
Rho GAPs and GEFs: controling switches in endothelial cell adhesionRas superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells.Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient EndotheliumNon-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilonRegulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancerCharacterization of EHop-016, novel small molecule inhibitor of Rac GTPaseRegulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.Evaluation of Vav3.1 as prognostic marker in endometrial cancer
P2860
Q26992281-CB64918A-E2D9-4A45-A223-C792880067ECQ27690752-8943E599-DD6A-44C7-9ABB-F82181B1D366Q30427158-33795075-39DA-4EB3-B02B-B7F1E5052791Q30498003-A4CEE1FA-B57C-4CFF-AEE0-C9FDDB283E11Q30646148-B8FE8E4F-02FD-4E76-8557-22EBB09BD15DQ34181904-7CCCD039-4D00-4216-AB80-B36F19DBFC55Q35165191-BFB8390D-1536-4844-944B-FDD85CD8B6F3Q35465076-AF022A8E-C637-4DCC-BC2E-4F9E6C3A73CCQ35921528-9CD3AAFA-F8F5-4366-9803-2C7EE17FB8DAQ36765650-6AE0307D-17AC-42B0-91AD-C28C3F1A6CF1Q37481159-3648843D-E7F3-4180-8490-7F09A8ADCC03Q38145091-196F97E4-284B-4993-B5EF-274DD9D2B526Q48197803-B46A5951-D9BE-4785-A583-960E2AB50640Q49500445-7A2ADE3B-D79D-4C41-97BB-3E8973CB244DQ57141071-95A2FC1D-FFA7-4ED9-A5E4-0E040AD405F7
P2860
Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@en
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@nl
type
label
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@en
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@nl
prefLabel
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@en
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@nl
P2093
P2860
P1476
Host deficiency in Vav2/3 guan ...... val, and angiogenesis in vivo.
@en
P2093
Dana M Brantley-Sieders
David Vaught
Donna Hicks
Guanglei Zhuang
Tanner Freeman
Yoonha Hwang
P2860
P304
P356
10.1158/1541-7786.MCR-08-0401
P577
2009-05-12T00:00:00Z